Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome

By Pau Elena   Alonso-Muriel Isabel   Gómez Raul   Novella Edurne   Ruiz Amparo   García-Velasco Juan A.   Simón Carlos   Pellicer Antonio  

Human Reproduction, Vol. 21, Iss. 6, 2006-06 ,pp. : 1453-1460

Oxford University Press

Access to resources Recommend Favorite

Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome

By Ludwig M   Bauer O   Lopens A   Jelkmann W   Diedrich K  

Human Reproduction, Vol. 13, Iss. 1, 1998-01 ,pp. : 30-32

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration

By Ludwig M.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2437-2441

Oxford University Press

Access to resources Recommend Favorite

Reproductive pathology. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome

By Chen Chin-Der   Wu Ming-Yih   Chen Hsin-Fu   Chen Shee-Uan   Ho Hong-Nerng  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 66-71

Oxford University Press

Access to resources Recommend Favorite

Infertility. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome

By Koike Toshimitsu   Araki Shigeo   Minakami Hisanori   Ogawa Shuichi   Sayama Masaaki   Shibahara Hiroaki  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 113-117

Oxford University Press

Access to resources Recommend Favorite